A Phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149)

[1]  D. Stewart,et al.  Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study , 2004, Journal of Neuro-Oncology.

[2]  J. Maroun,et al.  Cisplatin plus cytosine arabinoside in adults with malignant gliomas , 2004, Journal of Neuro-Oncology.

[3]  K. Albain,et al.  Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model , 2004, Cancer Chemotherapy and Pharmacology.

[4]  R. Hellman,et al.  Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  R. Fisher,et al.  Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: summary of an in vitro model and initial clinical pilot experience. , 1992, Seminars in oncology.

[6]  R. Fisher,et al.  1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking. , 1989, Cancer research.

[7]  J. Allen,et al.  Cisplatin in the treatment of recurrent childhood primary brain tumors. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  W. Shapiro.  Therapy of adult malignant brain tumors: what have the clinical trials taught us? , 1986, Seminars in oncology.

[9]  M. Marinus,et al.  Studies on mutagenesis and repair induced by platinum analogs. , 1986, Mutation research.

[10]  P. Lohman,et al.  Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II). , 1985, Cancer research.

[11]  D. Kufe,et al.  Effect of 1-beta-D-arabinofuranosyl cytosine and hydroxyurea on the repair of X-ray-induced DNA single-strand breaks in human leukemic blasts. , 1985, Biochemical pharmacology.

[12]  R. Weichselbaum,et al.  Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair. , 1984, Molecular pharmacology.

[13]  R. Snyder.  The role of deoxynucleoside triphosphate pools in the inhibition of DNA-excision repair and replication in human cells by hydroxyurea. , 1984, Mutation research.

[14]  R. Caprioli,et al.  Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. , 1982, Cancer research.

[15]  H. Uchino,et al.  Effects of anticancer platinum compounds on Escherichia coli strains with normal and defective DNA repair capacity. , 1981, Gan.

[16]  S. Howell,et al.  Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D P Byar,et al.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.

[18]  R. Craig,et al.  Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells. , 1980, Cancer research.

[19]  S. Linn,et al.  Apurinic/apyrimidinic endonucleases in repair of pyrimidine dimers and other lesions in DNA. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Regan,et al.  Inhibition of DNA excision repair in human cells by arabinofuranosyl cytosine: effect on normal and xeroderma pigmentosum cells. , 1979, Molecular pharmacology.

[21]  E. Alexander,et al.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.

[22]  C. Rawlings,et al.  Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus. , 1978, Mutation research.

[23]  R. J. Preston,et al.  The effect of cytosine arabinoside on the frequency of single-strand breaks in DNA of mammalian cells following irradiation or chemical treatment. , 1977, Biochimica et biophysica acta.

[24]  R. Brubaker,et al.  Effect of cis-Platinum(II)Diamminodichloride on Wild Type and Deoxyribonucleic Acid Repair-Deficient Mutants of Escherichia coli , 1973, Journal of bacteriology.